You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

esophageal squamous cell carcinoma

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Two-field or Three-field Lymphadenectomy on Overall Survival in

Completed
  • Esophageal Cancer
  • Since the data were collected retrospectively, there were no interventions
  • Chendu, Sichuan, China
    Sichuan Cancer Hospital
Nov 18, 2022

Esophageal Squamous Cell Carcinoma, Patient-reported Outcomes, Immunotherapy Trial in Guangzhou (drug, radiation, procedure)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • +2 more
  • Guangzhou, Guangdong, China
    Guangdong Provincial People's Hospital
Nov 24, 2022

Esophageal Squamous Cell Carcinoma Abdominal Stage 0 Trial in Guangzhou (PD-1 Inhibitors, Irinotecan, Capecitabine tablets)

Recruiting
  • Esophageal Squamous Cell Carcinoma Abdominal Stage 0
  • PD-1 Inhibitors
  • +2 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Feb 20, 2023

Hepatocellular Carcinoma, Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancers Trial (ABBV-400)

Not yet recruiting
  • Hepatocellular Carcinoma
  • +6 more
  • (no location specified)
Oct 10, 2023

PARP Inhibitor for Esophageal Squamous Cell Carcinoma Trial (Fluzoparib monotherapy or Fluzoparib with Camrelizumab(Only

Not yet recruiting
  • PARP Inhibitor for Esophageal Squamous Cell Carcinoma
  • Fluzoparib monotherapy or Fluzoparib with Camrelizumab(Only non-small cell lung cancer arm) ,or Fluzoparib combined with capecitabine (only rectal cancer arm))
  • (no location specified)
Sep 24, 2023

Esophageal Cancer, Metastatic Cancer, Squamous Cell Carcinoma Trial in Taipei City (Cabozantinib 40 MG, Atezolizumab Injection)

Recruiting
  • Esophageal Cancer
  • +2 more
  • Cabozantinib 40 MG
  • Atezolizumab Injection
  • Taipei City, Taiwan
    National Taiwan University Hospital
Sep 15, 2022

Non-metastatic, Non-recurrent Lung and Esophageal Cancer

Recruiting
  • Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
  • +55 more
  • Biospecimen Collection
  • +3 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Jan 5, 2023

Esophageal Squamous Cell Carcinoma Trial in Zhengzhou (Sintilimab)

Active, not recruiting
  • Esophageal Squamous Cell Carcinoma
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Aug 8, 2022

Immunotherapy Esophagus Cancer Trial (Tislelizumab, Albumin paclitaxel, Nedaplatin)

Not yet recruiting
  • Immunotherapy Esophagus Cancer
  • (no location specified)
Aug 24, 2022

Advanced Esophageal Squamous Cell Carcinoma Trial in China (TQB2618 injection, Penpulimab injection, Paclitaxel, Cisplatin,

Not yet recruiting
  • Advanced Esophageal Squamous Cell Carcinoma
  • TQB2618 injection, Penpulimab injection, Paclitaxel, Cisplatin
  • +2 more
  • Tongling, Anhui, China
  • +9 more
Apr 18, 2023

ESCC Trial (Tislelizumab combined with chemoradiotherapy)

Not yet recruiting
  • ESCC
  • Tislelizumab combined with chemoradiotherapy
  • (no location specified)
Sep 18, 2022

Recurrent or Metastatic Esophageal Squamous Cell Carcinoma Trial (SBRT, Cadonilimab)

Not yet recruiting
  • Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
  • (no location specified)
Feb 8, 2023

Esophageal Squamous Cell Carcinoma Trial in Shanghai (Penpulimab Combined With CRT)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • Penpulimab Combined With CRT
  • Shanghai, Shanghai, China
    Zhongshan Hospital
Sep 28, 2022

Esophageal Cancer, Head and Neck Squamous Cell Carcinoma, Advanced Head and Neck Squamous Cell Carcinoma Trial (LSTA1,

Not yet recruiting
  • Esophageal Cancer
  • +9 more
  • (no location specified)
Feb 2, 2023

Locally Advanced Esophageal Squamous Cell Carcinoma Trial (Tiragolumab)

Not yet recruiting
  • Locally Advanced Esophageal Squamous Cell Carcinoma
  • (no location specified)
Feb 23, 2023

Esophageal Squamous Cell Carcinoma Trial in Tokyo (FLOT therapy)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • FLOT therapy
  • Tokyo, Japan
    Keio University Hospital
Aug 15, 2022

Esophageal Squamous Cell Carcinoma Trial in Shanghai (Chemotherapy (nab-paclitaxel AUC=2 and carboplatin 80mg/m2),Immunotherapy

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • Chemotherapy (nab-paclitaxel AUC=2 and carboplatin 80mg/m2)，Immunotherapy (camrelizumab 200mg)、Radiotherapy(primary lesion and adjacent lymph nodes 41.4Gy， distant lymph node 0.5Gy*4)
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Dec 6, 2022

Esophageal Carcinoma Trial in Tianjin (camrelizumab)

Recruiting
  • Esophageal Carcinoma
  • Tianjin, China
    Tianjin Medical University Cancer Institute & Hospital
Jul 25, 2022

Esophageal Squamous Cell Carcinoma, Esophagectomy, Radiotherapy Trial (Since the data were collected retrospectively, there were

Completed
  • Esophageal Squamous Cell Carcinoma
  • +3 more
  • Since the data were collected retrospectively, there were no interventions
  • (no location specified)
Oct 31, 2022

Metastatic Esophageal Squamous Cell Carcinoma Trial in Guangzhou (Intensity-modulated radiotherapy concurrent with capecitabine)

Recruiting
  • Metastatic Esophageal Squamous Cell Carcinoma
  • Intensity-modulated radiotherapy concurrent with capecitabine
  • Guangzhou, Guangdong, China
    Sun yat-sen University Cancer center
Aug 21, 2022

RESECTED LYMPH NODES AND SURVIVAL OF PATIENTS WITH ESOPHAGEAL

Recruiting
  • the Records of Esophageal Cancer
  • Since the data were collected retrospectively, there were no interventions
  • Chendu, Sichuan, China
    Sichuan Cancer Hospital
Oct 24, 2022

Esophageal Squamous Cell Carcinoma by AJCC V8 Stage, Unresectable Trial in Tianjin (tislelizumab+ Paclitaxel + Cisplatin)

Recruiting
  • Esophageal Squamous Cell Carcinoma by AJCC V8 Stage
  • Unresectable
  • tislelizumab+ Paclitaxel + Cisplatin
  • Tianjin, Tianjin, China
    Hongjing Jiang
Jul 7, 2022

Esophageal Squamous Cell Carcinoma Trial in Chongqing (Tislelizumab)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • Chongqing, Chongqing, China
    Army Medical Center of the People's Liberation Army
May 26, 2023

Local Advanced Esophageal Carcinoma

Recruiting
  • Esophageal Squamous Cell Carcinoma
    • Shanghai, Shanghai, China
      Fudan University Shanghai cancer center
    Jun 16, 2022

    Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma

    Recruiting
    • Esophageal Cancer
    • Adjuvant Radiotherapy
    • Beijing, Chaoyang, China
      Cancer Institute and Hospital, Chinese Academy of Medical Scienc
    Jul 13, 2022